E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/24/2011 in the Prospect News PIPE Daily.

FluoroPharma Medical settles $1.64 million private placement of stock

Agents Noble Financial, Monarch Capital, Burnham Hill assist with sale

By Devika Patel

Knoxville, Tenn., June 24 - FluoroPharma Medical Inc. completed a $1.64 million private placement of stock on June 22, according to an 8-K filed Friday with the Securities and Exchange Commission. Noble Financial Capital Markets, Monarch Capital Group, LLC and Burnham Hill Partners LLC were the agents.

The company sold 1,976,351 common shares at $0.83 apiece. Investors also received 691,723 four-year warrants, which are each exercisable at $1.33. The strike price is a 5% discount to the June 21 closing share price of $1.40.

Proceeds will be used for working capital purposes.

The biopharmaceutical company is based in Boston.

Issuer:FluoroPharma Medical Inc.
Issue:Common stock
Amount:$1,640,371
Shares:1,976,351
Price:$0.83
Warrants:691,723 warrants
Warrant expiration:Four years
Warrant strike price:$1.33
Agent:Noble Financial Capital Markets, Monarch Capital Group, LLC and Burnham Hill Partners LLC
Settlement date:June 22
Stock symbol:OTCBB: FPMI
Stock price:$1.40 at close June 22
Market capitalization:$28.18 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.